Intercomparison of dose enhancement ratio and secondary electron spectra for gold nanoparticles irradiated by X-rays calculated using multiple Monte Carlo simulation codes.


Journal

Physica medica : PM : an international journal devoted to the applications of physics to medicine and biology : official journal of the Italian Association of Biomedical Physics (AIFB)
ISSN: 1724-191X
Titre abrégé: Phys Med
Pays: Italy
ID NLM: 9302888

Informations de publication

Date de publication:
Jan 2020
Historique:
received: 04 02 2019
revised: 29 11 2019
accepted: 15 12 2019
pubmed: 10 1 2020
medline: 27 10 2020
entrez: 10 1 2020
Statut: ppublish

Résumé

Targeted radiation therapy has seen an increased interest in the past decade. In vitro and in vivo experiments showed enhanced radiation doses due to gold nanoparticles (GNPs) to tumors in mice and demonstrated a high potential for clinical application. However, finding a functionalized molecular formulation for actively targeting GNPs in tumor cells is challenging. Furthermore, the enhanced energy deposition by secondary electrons around GNPs, particularly by short-ranged Auger electrons is difficult to measure. Computational models, such as Monte Carlo (MC) radiation transport codes, have been used to estimate the physical quantities and effects of GNPs. However, as these codes differ from one to another, the reliability of physical and dosimetric quantities needs to be established at cellular and molecular levels, so that the subsequent biological effects can be assessed quantitatively. In this work, irradiation of single GNPs of 50 nm and 100 nm diameter by X-ray spectra generated by 50 and 100 peak kilovoltages was simulated for a defined geometry setup, by applying multiple MC codes in the EURADOS framework. The mean dose enhancement ratio of the first 10 nm-thick water shell around a 100 nm GNP ranges from 400 for 100 kVp X-rays to 600 for 50 kVp X-rays with large uncertainty factors up to 2.3. It is concluded that the absolute dose enhancement effects have large uncertainties and need an inter-code intercomparison for a high quality assurance; relative properties may be a better measure until more experimental data is available to constrain the models.

Identifiants

pubmed: 31918367
pii: S1120-1797(19)30532-0
doi: 10.1016/j.ejmp.2019.12.011
pmc: PMC7446940
mid: NIHMS1569380
pii:
doi:

Substances chimiques

Water 059QF0KO0R
Gold 7440-57-5

Types de publication

Comparative Study Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

147-163

Subventions

Organisme : NCI NIH HHS
ID : R01 CA187003
Pays : United States

Commentaires et corrections

Type : ErratumIn

Informations de copyright

Copyright © 2019 Associazione Italiana di Fisica Medica. All rights reserved.

Références

Mol Pharm. 2010 Dec 6;7(6):2194-206
pubmed: 20973534
Mutat Res. 2011 Jun 3;711(1-2):28-40
pubmed: 21281649
J Phys Chem B. 2007 Oct 11;111(40):11622-5
pubmed: 17854220
Int J Nanomedicine. 2015 Sep 08;10:5687-700
pubmed: 26392771
Nanomedicine. 2010 Feb;6(1):161-9
pubmed: 19447206
Science. 2000 Mar 3;287(5458):1658-60
pubmed: 10698742
Biochim Biophys Acta. 2015 Aug;1856(1):130-43
pubmed: 26142869
Radiat Prot Dosimetry. 2006;122(1-4):89-94
pubmed: 17132665
Phys Med. 2017 Jan;33:207-215
pubmed: 28017738
Radiat Res. 2018 Nov;190(5):558-564
pubmed: 30142031
Phys Med Biol. 2009 Oct 7;54(19):N433-8
pubmed: 19724100
Radiat Res. 2010 Jun;173(6):719-28
pubmed: 20518651
Phys Med Biol. 2018 Jan 09;63(2):02TR01
pubmed: 29125831
Phys Med Biol. 2012 Dec 21;57(24):8309-23
pubmed: 23201628
Phys Rev Lett. 2013 Jun 21;110(25):258302
pubmed: 23829763
Med Phys. 2018 May;45(5):2230-2242
pubmed: 29480947
Med Phys. 2011 Feb;38(2):624-31
pubmed: 21452700
Proc Natl Acad Sci U S A. 2000 Jun 6;97(12):6264-6
pubmed: 10829074
Infect Immun. 2005 Apr;73(4):1907-16
pubmed: 15784530
Phys Rev A. 1994 Nov;50(5):3954-3967
pubmed: 9911367
Clin Oncol (R Coll Radiol). 2013 Oct;25(10):578-85
pubmed: 23849504
Nanoscale. 2014 Oct 21;6(20):12026-33
pubmed: 25182693
Phys Med Biol. 2004 Sep 21;49(18):N309-15
pubmed: 15509078
Proc Natl Acad Sci U S A. 2011 Jan 11;108(2):733-8
pubmed: 21187371
Phys Med Biol. 2015 Aug 21;60(16):6195-212
pubmed: 26226203
Radiat Environ Biophys. 2004 Sep;43(3):173-82
pubmed: 15526117
Sci Rep. 2017 Mar 27;7:45161
pubmed: 28345622
Int J Radiat Oncol Biol Phys. 2011 Feb 1;79(2):531-9
pubmed: 21095075
Phys Med Biol. 2009 Aug 21;54(16):4889-905
pubmed: 19636084
Mutat Res. 2013 Aug 30;756(1-2):213-23
pubmed: 23811166
Med Phys. 2013 Jul;40(7):071710
pubmed: 23822414
Med Phys. 2018 Jun 14;:
pubmed: 29901835
Phys Med Biol. 2014 Dec 21;59(24):7675-89
pubmed: 25415297
Phys Med. 2015 Dec;31(8):861-874
pubmed: 26653251
Nat Nanotechnol. 2011 Apr 24;6(6):385-91
pubmed: 21516092
Med Phys. 2012 Nov;39(11):6818-37
pubmed: 23127075
Radiat Res. 2003 Jan;159(1):3-22
pubmed: 12492364
Front Chem. 2014 Oct 14;2:86
pubmed: 25353018
Radiat Prot Dosimetry. 2016 Feb;168(2):223-34
pubmed: 25752758
Med Phys. 2010 Sep;37(9):4692-708
pubmed: 20964188
Br J Radiol. 2016;89(1059):20150200
pubmed: 26642305
Phys Med Biol. 2015 May 21;60(10):4149-68
pubmed: 25953956
Med Phys. 2007 Jun;34(6):2175-86
pubmed: 17654920
Ann ICRP. 2018 Oct;47(3-4):75-82
pubmed: 29664321
Med Phys. 2011 Aug;38(8):4531-4
pubmed: 21928623
Radiat Res. 2005 Jan;163(1):98-111
pubmed: 15606313
Radiat Res. 2017 Sep;188(3):355-368
pubmed: 28650774
Radiat Prot Dosimetry. 2019 May 1;183(1-2):11-16
pubmed: 30544197
Nano Lett. 2007 Jun;7(6):1542-50
pubmed: 17465586
Rep Prog Phys. 2016 Nov;79(11):116601
pubmed: 27652826
Radiat Res. 2019 Feb;191(2):125-138
pubmed: 30609382
Phys Med Biol. 2005 Aug 7;50(15):N163-73
pubmed: 16030374
Radiat Res. 2002 Nov;158(5):657-60
pubmed: 12385644
Phys Med Biol. 2013 May 21;58(10):3075-87
pubmed: 23594417
Phys Med Biol. 2019 Aug 07;64(15):155016
pubmed: 31300616
Phys Med. 2019 Feb;58:149-154
pubmed: 30642767
Med Phys. 2010 Jul;37(7):3809-16
pubmed: 20831089
Phys Med Biol. 2013 Nov 21;58(22):7961-77
pubmed: 24169737
Breast Cancer Res Treat. 2013 Jan;137(1):81-91
pubmed: 23160926
Phys Med Biol. 2008 Oct 21;53(20):5635-51
pubmed: 18812647
Phys Rev A Gen Phys. 1987 Nov 15;36(10):4684-4699
pubmed: 9898728
Radiat Prot Dosimetry. 2015 Sep;166(1-4):38-43
pubmed: 25883312
Phys Med Biol. 2011 Aug 7;56(15):4631-47
pubmed: 21734337
Nano Lett. 2006 Apr;6(4):662-8
pubmed: 16608261

Auteurs

W B Li (WB)

Institute of Radiation Medicine, Helmholtz Zentrum München - German Research Center for Environmental Health (GmbH), Ingolstädter Landstr. 1, 85764 Neuherberg, Germany. Electronic address: wli@helmholtz-muenchen.de.

A Belchior (A)

Centro de Ciências e Tecnologias Nucleares, Instituto Superior Técnico, Universidade de Lisboa, Estrada Nacional 10, 2695-066 Bobadela LRS, Portugal.

M Beuve (M)

Institut de Physique Nucléaire de Lyon, Université de Lyon, Université Claude Bernard Lyon 1, CNRS/IN2P3 UMR 5822, Villeurbanne, France.

Y Z Chen (YZ)

Department of Engineering Physics, Tsinghua University, Beijing, China.

S Di Maria (S)

Centro de Ciências e Tecnologias Nucleares, Instituto Superior Técnico, Universidade de Lisboa, Estrada Nacional 10, 2695-066 Bobadela LRS, Portugal.

W Friedland (W)

Institute of Radiation Medicine, Helmholtz Zentrum München - German Research Center for Environmental Health (GmbH), Ingolstädter Landstr. 1, 85764 Neuherberg, Germany.

B Gervais (B)

Normandie University, ENSICAEN, UNICAEN, CEA, CNRS, CIMAP, UMR 6252, BP 5133, F-14070 Caen Cedex 05, France.

B Heide (B)

Karlsruhe Institute of Technology, Karlsruhe, Germany.

N Hocine (N)

Institut de Radioprotection et de Sûreté Nucléaire, Fontenay-Aux-Roses, France.

A Ipatov (A)

Alferov Federal State Budgetary Institution of Higher Education and Science Saint Petersburg National Research Academic University of the Russian Academy of Sciences, St. Petersburg, Russia.

A P Klapproth (AP)

Institute of Radiation Medicine, Helmholtz Zentrum München - German Research Center for Environmental Health (GmbH), Ingolstädter Landstr. 1, 85764 Neuherberg, Germany; TranslaTUM, Klinikum rechts der Isar, Technische Universität München, Munich, Germany.

C Y Li (CY)

Department of Engineering Physics, Tsinghua University, Beijing, China; Nuctech Company Limited, Beijing, China.

J L Li (JL)

Department of Engineering Physics, Tsinghua University, Beijing, China.

G Multhoff (G)

TranslaTUM, Klinikum rechts der Isar, Technische Universität München, Munich, Germany.

F Poignant (F)

Institut de Physique Nucléaire de Lyon, Université de Lyon, Université Claude Bernard Lyon 1, CNRS/IN2P3 UMR 5822, Villeurbanne, France.

R Qiu (R)

Department of Engineering Physics, Tsinghua University, Beijing, China.

H Rabus (H)

Physikalisch-Technische Bundesanstalt, Braunschweig, Germany.

B Rudek (B)

Physikalisch-Technische Bundesanstalt, Braunschweig, Germany; Massachusetts General Hospital & Harvard Medical School, Department of Radiation Oncology, Boston, MA, USA.

J Schuemann (J)

Massachusetts General Hospital & Harvard Medical School, Department of Radiation Oncology, Boston, MA, USA.

S Stangl (S)

TranslaTUM, Klinikum rechts der Isar, Technische Universität München, Munich, Germany.

E Testa (E)

Institut de Physique Nucléaire de Lyon, Université de Lyon, Université Claude Bernard Lyon 1, CNRS/IN2P3 UMR 5822, Villeurbanne, France.

C Villagrasa (C)

Institut de Radioprotection et de Sûreté Nucléaire, Fontenay-Aux-Roses, France.

W Z Xie (WZ)

Department of Engineering Physics, Tsinghua University, Beijing, China.

Y B Zhang (YB)

Peking University Cancer Hospital, Beijing, China.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH